Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

391
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
391
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

738
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
738
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

548
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
548
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

556
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
556
Actuarial Approach01:20

Actuarial Approach

284
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
284
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.0K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.

Gynecologic oncology·2026
Same author

Predicting immune-related thyroiditis using polygenic risk scores in patients with advanced melanoma.

Journal for immunotherapy of cancer·2026
Same author

Power and sample-size estimation in human microbiome research.

Med (New York, N.Y.)·2026
Same author

The Oncology Research Information Exchange Network (ORIEN) - Building a real-world collaborative, patient-driven infrastructure for discovery research and precision oncology.

Research square·2026
Same author

How the Ketogenic Diet Shapes the Microbiome to Influence Cancer Immunotherapy Outcomes: An Exploration of Clinical Trials and Their Results.

Nutrition and cancer·2026
Same author

Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancer.

Journal for immunotherapy of cancer·2026
Same journal

Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis.

NPJ precision oncology·2026
Same journal

GLP-1 receptor agonist targets an AMPKα1-HIF1α-PFKFB3 metabolic vulnerability and enhances Lenvatinib response in hepatocellular carcinoma.

NPJ precision oncology·2026
Same journal

Redefining therapeutic horizons in thymic epithelial tumors: precision, combinations, and emerging biology.

NPJ precision oncology·2026
Same journal

Cell-free DNA dynamics and progression-free survival in metastatic gastroesophageal adenocarcinoma: insights from the REGIRI-PRODIGE 58 ancillary study.

NPJ precision oncology·2026
Same journal

OncoGen.AI: an integrated platform for automated genomic analysis and reporting in precision oncology.

NPJ precision oncology·2026
Same journal

Deep learning-driven MRI radiomics reveals biological subtypes and predicts recurrence risk in rectal cancer.

NPJ precision oncology·2026
查看所有相关文章

相关实验视频

Updated: Jan 14, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

闪亮的事件:协调纵向数据用于现实世界的生存率估计.

Alyssa Obermayer1,2, Joshua Davis3, Divya Priyanka Talada3

  • 1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Alyssa.Obermayer@Moffitt.org.

NPJ precision oncology
|January 12, 2026
PubMed
概括
此摘要是机器生成的。

ShinyEvents是一个新的网络工具,可以随着时间的推移分析患者治疗数据. 它将治疗事件与生存结果联系起来,有助于临床研究和数据分析.

更多相关视频

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.9K
Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

6.8K

相关实验视频

Last Updated: Jan 14, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.9K
Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

6.8K

科学领域:

  • 在瘤学瘤学.
  • 生物信息学是一种生物信息学.
  • 数据科学数据科学数据科学

背景情况:

  • 纵向数据分析对于了解治疗结果至关重要.
  • 现有的工具很难整合多层时间序列数据,并将治疗与生存联系起来.
  • 这种差距阻碍了对患者治疗过程的全面分析.

研究的目的:

  • 开发ShinyEvents,一个基于Web的框架,用于复杂的纵向数据分析.
  • 为了使多层时间序列数据与生存分析能够集成.
  • 为了促进临床医生和数据科学家之间的透明和可重复的合作.

主要方法:

  • 开发了ShinyEvents,这是一个基于Web的框架,用于纵向数据分析.
  • 实施了临床事件和队列可视化的交互时间表 (Sankey,Swimmer图).
  • 能够推断现实世界无进展生存率 (rwPFS) 和生存分析 (Kaplan-Meier,Cox回归).

主要成果:

  • 闪亮的事件允许队列级别的分析,包括治疗聚类和终点分配.
  • 该工具有效地可视化了患者的旅程和治疗线路.
  • 对肌肉侵入性膀癌患者的病例研究表明,思丁和凝丁改善了rwPFS和整体存活率.

结论:

  • 闪亮的事件提供了一个统一的框架,用于整合纵向真实世界的数据与生存分析.
  • 该工具支持将治疗线与临床结果关联起来.
  • 闪亮的事件增强了瘤学和数据科学领域的合作研究.